![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 16, 2007 9:42:11 AM
Posted: 2007-10-16 09:27:22
CHARLES TOWN, W.Va., Oct. 16 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) today announced that they have agreed upon a Joint Venture with UFFE Medical, LTD, parent company to SIMpill UK to distribute the ReBuilder Medical's unique home treatment for the skin disease Molluscum Contagiosum that affects primarily children and presents with sometimes hundreds of pimple-like lesions that can take years to resolve if not treated. UFFE Medical LTD is located at the Mortlake Business Center in London. Information about SIMpill can be found at http://www.simpill.co.uk .
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM